MORGAN STANLEY

Holdings History for MADRIGAL PHARMACEUTICALS, INC. - COM (MDGL)

Symbol: MDGL on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$57.2M	269K	+49,363	+22.4%	$212.22	Q3 2024
6/30/2024	0%	0%	$61.6M	220K	-68,574	-23.8%	$280.16	Q2 2024
3/31/2024			$363	1			$363.00^*	Q1 2024
3/31/2024	0.01%	+0%	$77.1M	289K	+136,688	+90%	$267.04	Q1 2024
12/31/2023			$332	1			$332.00^*	Q4 2023
12/31/2023	0%	0%	$35.2M	152K	-19,856	-11.6%	$231.38	Q4 2023
9/30/2023	0%	+0%	$25.1M	172K	+97,480	+131%	$146.04	Q3 2023
6/30/2023	0%	0%	$17.2M	74.3K	-73,486	-49.7%	$231.00	Q2 2023
3/31/2023	0%	+0%	$35.8M	148K	+38,359	+35.1%	$242.26	Q1 2023
12/31/2022	0%	+0%	$31.8M	109K	+50,362	+85.3%	$290.25	Q4 2022
9/30/2022	0%	0%	$3.84M	59.1K	-23,891	-28.8%	$64.99	Q3 2022
6/30/2022	0%	0%	$5.94M	82.9K	-15,071	-15.4%	$71.60	Q2 2022
3/31/2022	0%	+0%	$9.62M	98K	+49,686	+103%	$98.11	Q1 2022
12/31/2021	0%	0%	$4.1M	48.3K	-19,830	-29.1%	$84.76	Q4 2021
9/30/2021	0%	0%	$5.44M	68.2K	-25,508	-27.2%	$79.78	Q3 2021
6/30/2021	0%	0%	$9.13M	93.7K	-169,222	-64.4%	$97.43	Q2 2021
3/31/2021	0%	+0%	$30.8M	263K	+211,307	+410%	$116.97	Q1 2021
12/31/2020	0%	+0%	$5.73M	51.6K	+23,527	+83.8%	$111.15	Q4 2020
9/30/2020	0%	+0%	$3.33M	28.1K	+1,406	+5.28%	$118.75	Q3 2020
6/30/2020	0%	+0%	$3.02M	26.7K	+1,880	+7.59%	$113.23	Q2 2020
3/31/2020	0%	+0%	$1.65M	24.8K	+1,110	+4.69%	$66.72	Q1 2020
12/31/2019	0%	0%	$2.16M	23.7K	-11,319	-32.4%	$91.11	Q4 2019
9/30/2019	0%	+0%	$3.02M	35K	+20,479	+141%	$86.24	Q3 2019
6/30/2019	0%	+0%	$1.52M	14.5K	+1,064	+7.92%	$104.87	Q2 2019
3/31/2019	0%	0%	$1.68M	13.4K	-50,539	-79%	$125.30	Q1 2019
12/31/2018	0%	+0%	$7.21M	64K	+42,296	+195%	$112.72	Q4 2018
9/30/2018	0%	0%	$4.64M	21.7K	-2,089	-8.79%	$214.13	Q3 2018
6/30/2018	0%	+0%	$6.65M	23.8K	+11,472	+93.3%	$279.70	Q2 2018
3/31/2018	0%	+0%	$1.44M	12.3K	+2,183	+21.6%	$116.75	Q1 2018
12/31/2017	0%	+0%	$928K	10.1K	+4,471	+79.2%	$91.73	Q4 2017
9/30/2017	0%	+0%	$255K	5.65K	+1,879	+49.9%	$45.16	Q3 2017
6/30/2017			$2K	161			$12.42^*	Q2 2017
6/30/2017	0%	+0%	$61K	3.77K	+1,677	+80.2%	$16.19	Q2 2017
3/31/2017			$1K	82			$12.20^*	Q1 2017
3/31/2017	0%	+0%	$32K	2.09K	+1,758	+530%	$15.31	Q1 2017
12/31/2016	0%		$5K	332	+82	+32.8%	$15.06	Q4 2016
9/30/2016	0%	+0%	$3K	250	+250	NEW	$12.00	Q3 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.